Beyond the Burden: “A New Standard for Stable, Flare Free AD Control”

Overview

“Beyond the Burden: A New Standard for Stable, Flare Free AD Control”, where leading dermatologists will discuss the science behind stable response in AD, and address the persistent disease burden for patients with moderate-to-severe AD.

This Activity for

• Resident / Fellow
• Physician
• Pharmacy
• Clinical Pharmacy

What I will learn?

1. Learn more about the latest efficacy data of Ebglyss, highlighting how patients maintain skin clearance and itch relief.
2. Review the clinical benefits of lebrikizumab through real-life patient cases

About Organizer

• Virtual Medical Academy

Additional items to the activity

Optional Details	Type	Fee